Doximity earnings analysis: questions answered and next catalysts

Doximity Inc (DOCS) reported its Q2 2027 earnings on November 5, 2026, with earnings per share (EPS) at $0.36, exceeding estimates of $0.35. Revenue for the quarter was $174.5 million, marking a 4% year-over-year increase. Adj. EBITDA margin, however, stood at 51%, a decline from 60% the previous year. The stock initially dropped to $30.44 pre-market, but has since recovered part of that loss.

DOCS has been known for its erratic moves, with a 21%, 32%, and 27% decline on the last three earnings reports, indicating volatility. The 52-week trading range is $17.15–$58.24, and DOCS has experienced a 49% decline over the past year but a 54% increase over the last three months. Should the stock fall below $30, it would break today's pre-market low, while a rise above $35 would suggest that the post-earnings dip has been absorbed.

The figures are based on the dates mentioned. The consensus numbers and the February 11 earnings date are provisional and subject to change.